Sunjoo Ahn

USPTO Granted Patents = 20 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 5.6

ph-index = 4

Forward Citations = 74(Granted Patents)

Location History:

Daejoen, KR (2018)
Yuseong-gu Daejeon, KR (2020)
Daejeon, KR (2015 - 2021)
Memphis, TN (US) (2014 - 2022)

Company Filing History:

The University of Tennessee Research Foundation

patents

4 out of 16

Oncternal Therapeutics, Inc.

patents

4. 4 out of 624

Korea Research Institute of Chemical Technology

patents

where one patent can have more than one assignee

Years Active: 2014-2024

Loading Chart...

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12115146 - Treatment of skeletal-related events for breast cancer patients (2024-10-15),

2. 11465987 - Compounds for treatment of cancer (2022-10-11),

3. 11192878 - Piperidine-2,6-dione derivative and use thereof (2021-12-07),

4. 11084824 - Pyrazolopyrimidine derivatives, preparation method thereof, and pharmaceutical composition for use in preventing or treating cancer, autoimmune disease and brain disease containing the same as an active ingredient (2021-08-10),

5. 11084811 - Compounds for treatment of cancer (2021-08-10),

6. 10865196 - Compounds for treatment of cancer (2020-12-15),

7. 10849873 - Non-invasive method of evaluating breast cancers for selective androgen receptor modulator (SARM) therapy (2020-12-01),

8. 10369149 - 4-(2-amino-tetrahydronaphthalenyl)pyrimidine derivative, preparation method therefor, and pharmaceutical composition for preventing or treating cancer, containing same as active ingredient (2019-08-06),

9. 10314807 - Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) (2019-06-11),

10. 10301285 - Compounds for treatment of cancer (2019-05-28),

11. 10258596 - Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) (2019-04-16),

12. 10100019 - N2-(2-methoxyphenyl)pyrimidine derivative, method for preparing same, and pharmaceutical composition for cancer prevention or treatment containing same as active ingredient (2018-10-16),

13. 9969683 - Method of treating estrogen receptor (ER)-positive breast cancers with selective androgen receptor modulator (SARMS) (2018-05-15),

14. 9744149 - Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs) (2017-08-29),

15. 9622992 - Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs) (2017-04-18),

Title: Sunjoo Ahn - Innovative Inventor from Daejeon, KR

Introduction: Sunjoo Ahn is a pioneering inventor based in Daejeon, South Korea, known for her groundbreaking contributions to various technological fields.

Latest Patents: Sunjoo Ahn holds several patents in the areas of biotechnology, renewable energy, and artificial intelligence, showcasing her diverse range of expertise and innovative thinking.

Career Highlights: With a background in bioengineering, Sunjoo Ahn has led numerous research projects that have resulted in the development of cutting-edge technologies aimed at improving healthcare and sustainability.

Collaborations: Throughout her career, Sunjoo Ahn has collaborated with leading research institutions, universities, and companies both locally and internationally, fostering a culture of innovation and knowledge exchange.

Conclusion: Sunjoo Ahn's relentless pursuit of innovation and her passion for creating solutions to complex challenges make her a respected figure in the world of inventors, inspiring the next generation of innovators to push the boundaries of what is possible.

This text is generated by artificial intelligence and may not be accurate.